https://www.panabee.com/news/denifanstat-posts-52-week-data-as-sagimet-terminates-atm-offering
Denifanstat Posts 52-Week Data as Sagimet Terminates ATM Offering | SGMT News & Analysis
Sagimet Biosciences reported positive 52-week Phase 3 OLE results for its FASN inhibitor denifanstat in moderate to severe acne, with 57% treatment success....
news analysisdenifanstatpostsweekdata